Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 6
2016 4
2017 4
2018 9
2019 9
2020 11
2021 13
2022 8
2023 14
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Reviewing the Regulators of COL1A1.
Devos H, Zoidakis J, Roubelakis MG, Latosinska A, Vlahou A. Devos H, et al. Among authors: latosinska a. Int J Mol Sci. 2023 Jun 11;24(12):10004. doi: 10.3390/ijms241210004. Int J Mol Sci. 2023. PMID: 37373151 Free PMC article. Review.
Proteomics and Metabolomics for AKI Diagnosis.
Marx D, Metzger J, Pejchinovski M, Gil RB, Frantzi M, Latosinska A, Belczacka I, Heinzmann SS, Husi H, Zoidakis J, Klingele M, Herget-Rosenthal S. Marx D, et al. Among authors: latosinska a. Semin Nephrol. 2018 Jan;38(1):63-87. doi: 10.1016/j.semnephrol.2017.09.007. Semin Nephrol. 2018. PMID: 29291763 Review.
Drug repurposing in oncology.
Frantzi M, Latosinska A, Mokou M, Mischak H, Vlahou A. Frantzi M, et al. Among authors: latosinska a. Lancet Oncol. 2020 Dec;21(12):e543. doi: 10.1016/S1470-2045(20)30610-0. Lancet Oncol. 2020. PMID: 33271100 No abstract available.
Proteomics in Drug Development: The Dawn of a New Era?
Frantzi M, Latosinska A, Mischak H. Frantzi M, et al. Among authors: latosinska a. Proteomics Clin Appl. 2019 Mar;13(2):e1800087. doi: 10.1002/prca.201800087. Epub 2019 Feb 25. Proteomics Clin Appl. 2019. PMID: 30724014 Review.
Cardioprotection by selective SGLT-2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?
Nikolaou PE, Mylonas N, Makridakis M, Makrecka-Kuka M, Iliou A, Zerikiotis S, Efentakis P, Kampoukos S, Kostomitsopoulos N, Vilskersts R, Ikonomidis I, Lambadiari V, Zuurbier CJ, Latosinska A, Vlahou A, Dimitriadis G, Iliodromitis EK, Andreadou I. Nikolaou PE, et al. Among authors: latosinska a. Basic Res Cardiol. 2022 May 17;117(1):27. doi: 10.1007/s00395-022-00934-7. Basic Res Cardiol. 2022. PMID: 35581445
74 results